학술논문
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis
Document Type
Article
Author
Source
In: Cancer Treatment and Research Communications . (Cancer Treatment and Research Communications, January 2021, 27)
Subject
Language
English
ISSN
24682942